Surgery Partners (SGRY) closed at $15.75 on October 23, 2026, down 0.9% from the previous close, on volume of 3,226,490 shares (30-day average 1,995,967).
Data as of October 23, 2026.
23-Oct-2026
Market Chameleon (Fri, 18-Sep 7:05 AM ET)
Globe Newswire (Thu, 17-Sep 9:00 AM ET)
Surgery Partners, Inc. Announces Second Quarter 2026 Results Reaffirms Full Year 2026 Guidance
Globe Newswire (Mon, 10-Aug 7:30 AM ET)
Market Chameleon (Fri, 24-Jul 7:44 AM ET)
Surgery Partners Sets 2026 Guidance, Launches $200 Million Share Repurchase Amid Mixed 2025 Results
Market Chameleon (Tue, 3-Mar 2:38 AM ET)
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
Surgery Partners trades on the NASDAQ stock market under the symbol SGRY.
As of October 23, 2026, SGRY stock price declined to $15.75 with 3,226,490 million shares trading.
SGRY has a beta of 1.36, meaning it tends to be more sensitive to market movements. SGRY has a correlation of 0.09 to the broad based SPY ETF.
SGRY has a market cap of $2.06 billion. This is considered a Mid Cap stock.
Last quarter Surgery Partners reported $849 million in Revenue and $.10 earnings per share. This beat revenue expectation by $18 million and exceeded earnings estimates by $.05.
In the last 3 years, SGRY traded as high as $36.92 and as low as $11.41.
The top ETF exchange traded funds that SGRY belongs to (by Net Assets): DFSV, VTI, IWM, VB, DFAT.
SGRY has underperformed the market in the last year with a return of -28.3%, while SPY returned +14.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in SGRY shares. However, SGRY has outperformed the market in the last 3 month and 2 week periods, returning +3.5% and +13.4%, while SPY returned +3.2% and -2.4%, respectively. This indicates SGRY has been having a stronger performance recently.
SGRY support price is $15.47 and resistance is $16.33 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SGRY shares will trade within this expected range on the day.
